×

Red flag over Biogen's very expensive drug

1:23 PM ET Thu, 29 Dec 2016

CNBC's Meg Tirrell reports that one analyst is raising a red flag on Biogen due to the incredibly high price of a new drug to treat a rare genetic disease in children.